Level D· Scientific groundwork from lab and animal studiesNarrative ReviewPubMed

Role of adipose-associated lymphoid tissues in the immunological homeostasis of the serosal surface.

Jia X., Berta G., Gábris F., Kellermayer Z., Balogh P.

Narrative Review on Face & Skin, Systemic / IV, published in Immunol Lett (2020) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Immunol Lett (2020)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
33166529
DOI
10.1016/j.imlet.2020.11.001

Abstract (original English)

Although not typical lymphoid organs, analysis of the visceral adipose-associated lymphoid tissues has recently substantially expanded our knowledge about the immunological features of these elusive compartments. Recent data have highlighted their considerable complexity in cellular organization and interactions in several biological processes, including adaptive immune responses, tissue plasticity to accommodate mesenchymal stem cells and progenitors, and providing a suitable microenvironment for serosal tumor propagation. This review aims to present a comprehensive view of the adipose-associated lymphoid tissues in local and systemic immune responsiveness, with particular emphasis on the omental and mesenteric lymphoid tissues in the serosal defense of abdominal organs.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Abdominal FatAdaptive ImmunityAdipocytesAnimalsCell CommunicationHumansLymphoid TissueMesenchymal Stem CellsMyeloid CellsPeritoneal Neoplasms

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research